# EDGAR Filing Document

**Accession Number:** 0001807489
**File Stem:** 0000902664-25-003872
**Filing Date:** 2025-8
**Character Count:** 6849
**Document Hash:** 74788a7350d1e1d1b4ba399d5a0b7418
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000902664-25-003872.hdr.sgml**: 20250828

**ACCESSION NUMBER**: 0000902664-25-003872

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250828

**EFFECTIVENESS DATE**: 20250828

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** M28 Capital Management LP
- **CENTRAL INDEX KEY:** 0001807489

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-21846
- **FILM NUMBER:** 251270799

**BUSINESS ADDRESS:**
- **STREET 1:** 700 CANAL STREET, 1ST FLOOR
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06902
- **BUSINESS PHONE:** 203-516-3730

**MAIL ADDRESS:**
- **STREET 1:** 700 CANAL STREET, 1ST FLOOR
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06902

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001807489

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** M28 Capital Management LP

**Address:** 700 CANAL STREET, 1ST FLOOR, STAMFORD, CT 06902

**Telephone number:** 203-516-3730

**Name of agent for service:** Christopher M. Taliercio

**Agent Address:** 700 Canal Street, 1st Floor, Stamford, CT 06902

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-21846

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER               | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                              | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED    |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| WAVE LIFE SCIENCES LTD       | Y95308105 | 08/06/2024     | To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in the proxy statement              | SECTION 14A SAY-ON-PAY VOTES |        6500000 |                0 | FOR          |                                  6500000 | FOR                         |  |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | 03/12/2025     | Advisory Vote to Approve Executive Compensation                                                                                               | SECTION 14A SAY-ON-PAY VOTES |          67400 |                0 | FOR          |                                    67400 | FOR                         |  |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | 03/12/2025     | Advisory Vote on Frequency of Executive Compensation Advisory Votes.                                                                          | SECTION 14A SAY-ON-PAY VOTES |          67400 |                0 | 1 Year       |                                    67400 | FOR                         |  |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | 05/14/2025     | Non-binding advisory vote on executive compensation                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          55200 |                0 | FOR          |                                    55200 | FOR                         |  |
| CURIS INC                    | 231269309 | 05/20/2025     | To approve an advisory vote on executive compensation                                                                                         | SECTION 14A SAY-ON-PAY VOTES |         476268 |                0 | FOR          |                                   476268 | FOR                         |  |
| ROCKET PHARMACEUTICALS INC   | 77313F106 | 06/18/2025     | Consider and act upon a non-binding, advisory vote on the compensation of our named executive officers.                                       | SECTION 14A SAY-ON-PAY VOTES |         385680 |                0 | FOR          |                                   385680 | FOR                         |  |
| TG THERAPEUTICS INC          | 88322Q108 | 06/12/2025     | An advisory vote to approve the compensation of our named executive officers.                                                                 | SECTION 14A SAY-ON-PAY VOTES |         131268 |                0 | FOR          |                                   131268 | FOR                         |  |
| BRIDGEBIO PHARMA INC         | 10806X102 | 06/20/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.            | SECTION 14A SAY-ON-PAY VOTES |          53764 |                0 | FOR          |                                    53764 | FOR                         |  |
| SILENCE THERAPEUTICS PLC     | 82686Q101 | 06/26/2025     | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.                      | SECTION 14A SAY-ON-PAY VOTES |         185100 |                0 | FOR          |                                   185100 | FOR                         |  |
| SILENCE THERAPEUTICS PLC     | 82686Q101 | 06/26/2025     | To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | Did Not Vote |                                   185100 | NONE                        |  |

## N-PX: Signature Block

**Reporting Person:** M28 Capital Management LP

**By (Signature):** /s/ Christopher M. Taliercio

**By (Printed Signature):** /s/ Christopher M. Taliercio

**By (Title):** President and Chief Compliance Officer

**Date:** 08/28/2025